US Stock MarketDetailed Quotes
ENGN enGene Holdings
- 6.080
- -0.510-7.74%
Close Dec 13 16:00 ET
- 6.000
- -0.080-1.31%
Post 20:01 ET
309.94MMarket Cap-3.44P/E (TTM)
6.751High6.000Low964.37KVolume6.510Open6.590Pre Close6.29MTurnover3.29%Turnover RatioLossP/E (Static)50.98MShares18.40052wk High1.35P/B178.50MFloat Cap4.42052wk Low--Dividend TTM29.36MShs Float47.170Historical High--Div YieldTTM11.39%Amplitude4.420Historical Low6.526Avg Price1Lot Size
enGene Holdings Stock Forum
Sign in to post a comment
$enGene Holdings (ENGN.US)$
Detalimogene Demonstrates 71% Complete Response Rate at Any Time in Preliminary Analysis of LEGEND Pivotal Cohort
Data from pivotal cohort demonstrate compelling clinical activity, consistent with Phase 1 results
Favorable tolerability profile with no drug-related discontinuations
Detalimogene's profile to date supports its potential as a foundational therapy for NMIBC
enGene to host a conference call to discuss preliminary data today at 8:00 a.m. ET
enGene Hold...
Detalimogene Demonstrates 71% Complete Response Rate at Any Time in Preliminary Analysis of LEGEND Pivotal Cohort
Data from pivotal cohort demonstrate compelling clinical activity, consistent with Phase 1 results
Favorable tolerability profile with no drug-related discontinuations
Detalimogene's profile to date supports its potential as a foundational therapy for NMIBC
enGene to host a conference call to discuss preliminary data today at 8:00 a.m. ET
enGene Hold...
1
3
The position indicator has been the most helpful the last week with so many CB(circuit breakers) happening. I have been able to enter and exit with profits of 300% this week. Last week my stocks I had been holding for a long time finally came thru and my accounts went up 300%. So since July 16th I am up 600% and not planning on stopping.
My next high risk investment is $WeBuy Global (WBUY.US)$. They have until Monday to get their stock over a 1.00 or delisting procedur...
My next high risk investment is $WeBuy Global (WBUY.US)$. They have until Monday to get their stock over a 1.00 or delisting procedur...
11
7
1
The appointment of Lee Giguere, an experienced public biotech legal executive, is expected to strongly support enGene's growth as the company advances the development of EG-70 in its ongoing pivotal-stage LEGEND study in BCG-unresponsive non-muscle invasive bladder cancer.
$enGene Holdings (ENGN.US)$ dont you want to pop yet? what are you waiting for?
1
2
$enGene Holdings (ENGN.US)$ buy guys while is cheap here
No comment yet
Heat List
US
Overall
Symbol
Price
% Chg
No Data
Wins333 : Thanks for the update, but market responses otherwise got be something hidden
Jaguar8 OP Wins333 : Nowadays, I notice that market reaction tends to be delayed
Wins333 Jaguar8 OP : Agreed bro, I think that’s deliberated. I will say you have a great sense